Biliary cast syndrome after liver transplantation: A cholangiographic evolution study.


Journal

Journal of gastroenterology and hepatology
ISSN: 1440-1746
Titre abrégé: J Gastroenterol Hepatol
Pays: Australia
ID NLM: 8607909

Informations de publication

Date de publication:
May 2021
Historique:
revised: 20 09 2020
received: 06 05 2020
accepted: 24 10 2020
pubmed: 6 11 2020
medline: 2 10 2021
entrez: 5 11 2020
Statut: ppublish

Résumé

The aim of this study is to describe the cholangiographic features and endoscopic management of biliary cast syndrome (BCS), a rare specific ischemic cholangiopathy following liver transplantation. Patients with biliary complications were identified from prospectively collected database records of patients who underwent liver transplantation at the Erasme Hospital from January 2005 to December 2014. After excluding patients with hepatico-jejunostomy or no suspicion of stricture, cholangiograms obtained during endoscopic retrograde cholangiopancreatography (ERCP) and magnetic resonance imaging were systematically reviewed. Biliary complications were categorized as anastomotic (AS) and non-AS strictures, and patients with BCS were identified. Clinical, radiological, and endoscopic data were reviewed. Out of 311 liver transplantations, 14 cases were identified with BCS (4.5%) and treated with ERCP. Intraductal hyperintense signal on T1-weighted magnetic resonance and a "duct-in-a-duct" image were the most frequent features of BCS on magnetic resonance imaging. On initial ERCP, 57% of patients had no stricture. Complete cast extraction was achieved in 12/14, and one of these had cast recurrence. On follow-up, 85% of the patients developed biliary strictures that were treated with multiple plastic stents reaching 60% complete stricture resolution, but 40% of them had recurrence. After a median follow-up of 58 months, BCS patients had lower overall and graft survival (42.9% and 42.9%) compared with non-AS (68.8% and 56.3%) and AS (83.3% and 80.6%), respectively. Particular magnetic resonance-cholangiographic and ERCP-cholangiographic features of BCS have been identified. Outcomes for BCS are characterized by high complete cast extraction rates, high incidence of secondary strictures, and poorer prognosis.

Sections du résumé

BACKGROUND AND AIM OBJECTIVE
The aim of this study is to describe the cholangiographic features and endoscopic management of biliary cast syndrome (BCS), a rare specific ischemic cholangiopathy following liver transplantation.
METHODS METHODS
Patients with biliary complications were identified from prospectively collected database records of patients who underwent liver transplantation at the Erasme Hospital from January 2005 to December 2014. After excluding patients with hepatico-jejunostomy or no suspicion of stricture, cholangiograms obtained during endoscopic retrograde cholangiopancreatography (ERCP) and magnetic resonance imaging were systematically reviewed. Biliary complications were categorized as anastomotic (AS) and non-AS strictures, and patients with BCS were identified. Clinical, radiological, and endoscopic data were reviewed.
RESULTS RESULTS
Out of 311 liver transplantations, 14 cases were identified with BCS (4.5%) and treated with ERCP. Intraductal hyperintense signal on T1-weighted magnetic resonance and a "duct-in-a-duct" image were the most frequent features of BCS on magnetic resonance imaging. On initial ERCP, 57% of patients had no stricture. Complete cast extraction was achieved in 12/14, and one of these had cast recurrence. On follow-up, 85% of the patients developed biliary strictures that were treated with multiple plastic stents reaching 60% complete stricture resolution, but 40% of them had recurrence. After a median follow-up of 58 months, BCS patients had lower overall and graft survival (42.9% and 42.9%) compared with non-AS (68.8% and 56.3%) and AS (83.3% and 80.6%), respectively.
CONCLUSIONS CONCLUSIONS
Particular magnetic resonance-cholangiographic and ERCP-cholangiographic features of BCS have been identified. Outcomes for BCS are characterized by high complete cast extraction rates, high incidence of secondary strictures, and poorer prognosis.

Identifiants

pubmed: 33150992
doi: 10.1111/jgh.15318
doi:

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1366-1377

Informations de copyright

© 2020 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.

Références

Shah JN, Haigh WG, Lee SP et al. Biliary cast after orthotopic liver transplantation: clinical factors, treatment, biochemical analysis. Am. J. Gastroenterol. 2003; 98: 1861-1867.
Gor NV, Levy RM, Ahn J et al. Biliary cast syndrome following liver transplantation: predictive factors and clinical outcomes. Liver Transpl. 2008; 14: 1466-1472.
Paik WH, Lee SH, Ruy JK et al. Long term outcome of biliary cast syndrome in liver transplantation recipients. Liver Transpl. 2013; 19: 275-282.
Voigtländer T, Negm AA, Strassburg CP et al. Biliary cast syndrome post-liver transplantation: risk factors and outcome. Liver Int. 2013; 33: 1287.
Kinner S, Umutlu L, Dechêne A et al. Biliary complications after liver transplantation: addition of T1-weighted images to MR cholangiopancreatography facilitates detection of cast in biliary cast syndrome. Radiology 2012; 263: 429-436.
Yang YL, Zhang C, Lin MJ et al. Biliary cast after liver transplantation: morphology and biochemical analysis. World J. Gastroenterol. 2013; 19: 7772-7777.
Navaneethan U, Venkatesh PG, Al Mohajer M, Gelrud A. Successful diagnosis and management of biliary cast syndrome in a liver transplant patient using single operator cholangioscopy. JOP 2011; 12: 461-463.
Bukhari MA, Brewer O, Chen YI et al. Endosonography-guided alteration of upper surgical anatomy to facilitate endoscopic management of biliary cast syndrome post-liver transplantation. Endoscopy 2019 e-pub.
Karagyozov P, Tishkov I, Boeva I. Bile cast syndrome-a rare cause of biliary obstruction after liver transplantation successfully managed using digital single-operator cholangioscopy. Endoscopy 2019; 51: S228-S229.
Cintolo M, Tringali A, Forti E et al. Biliary cast syndrome after OLT: a single-center case series and literature review. Endoscopy 2018; 50: S71.
Larghi A, Tringali A, Rimbas M et al. Endoscopic management of benign biliary strictures after liver transplantation. Liver Transpl. 2019; 25: 323-335.
Buis CI, Verdonck RC, Van der Jagt E et al. Nonanastomotic biliary strictures after liver transplantation, part 1: radiological features and risk factors for early vs late presentation. Liver Transpl. 2007; 13: 708-718.
Tringali A, Barbaro F, Pizzicannella M et al. Endoscopic management with multiple plastic stents of anastomotic biliary stricture following liver transplantation: long-term results. Endoscopy 2016; 48: 546-551.
Poley JW, Lekkerkerker MN, Metselaar HJ, Kuipers EJ, Bruno MJ. Clinical outcome of progressive stenting in patients with anastomotic strictures after orthotopic liver transplantation. Endoscopy 2013; 45: 567-570.
Dumonceau JM, Tringali A, Papanikolaou IS et al. Endoscopic biliary stenting; indications, choic of stents, and results: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guidelines-updated October 2017. Endoscopy 2018; 50: 910-930.
Devière J, Reddy N, Püspök A et al. Successful management of benign biliary strictures with fully covered self-expandable metal stents. Gastroenterology 2014; 147: 385-395.
Tabibian JH, Asham EH, Golstein L et al. Endoscopic treatment with multiple stents for post-liver-transplantation nonanastomotic biliary strictures. Gastrointest. Endosc. 2009; 69: 1236-1243.
Barbaro F, Tringali A, Baldan A et al. Endoscopic management with plastic stents of nonanastomotic biliary strictures following liver transplantation: a single center experience. Endoscopy 2018; 50: S71.
Verdonk RC, Buis CI, van der Jagt E et al. Nonanastomotic biliary stricture after liver transplantation, part 2: management, outcome and risk factors for disease progression. Liver Transpl. 2007; 13: 725-732.
Landi F, de Angelis N, Sepulveda A et al. Endoscopic treatment of anastomotic biliary stricture after adult deceased donor liver transplantation with multiple plastic stents versus self-expandable metal stents: a systematic review and meta-analysis. Tanspl. Int. 2018; 31: 131-151.
Graziadei IW, Scwaighofer H, Koch R et al. Long-term outcome of endoscopic treatment of biliary strictures after liver transplantation. Liver Transpl. 2006; 12: 718-725.
Chang JH, Lee IS, Choi JY et al. Biliary stricture after adult right-lobe living donor liver transplantation with duct-to-duct anastomosis: long-term outcome and its related factors after endoscopic treatment. Gut Liver 2010; 4: 226-233.
Buxbaum JL, Biggins SW, Bagatelos KC, Ostroff JW. Predictors of endoscopic treatment outcomes in the management of biliary problems after liver transplantation at a high-volume academic center. Gastrointest. Endosc. 2011; 73: 37-44.
Arrivé L, Hodoul M, Arbache A et al. Magnetic resonance cholangiography: current and future perspectives. Clin. Res. Hepatol. Gastroenterol. 2015; 39: 659-664.

Auteurs

Arnaud Lemmers (A)

Department of Gastroenterology, Hepatopancreatology and Digestive Oncology, CUB Erasmus Hospital, ULB (Free University of Brussels), Brussels, Belgium.

Martina Pezzullo (M)

Department of Radiology, CUB Erasmus Hospital, ULB (Free University of Brussels), Brussels, Belgium.

Alia Hadefi (A)

Department of Gastroenterology, Hepatopancreatology and Digestive Oncology, CUB Erasmus Hospital, ULB (Free University of Brussels), Brussels, Belgium.

Séverine Dept (S)

Department of Gastroenterology, Hepatopancreatology and Digestive Oncology, CUB Erasmus Hospital, ULB (Free University of Brussels), Brussels, Belgium.

Desislava Germanova (D)

Department of Abdominal Surgery, CUB Erasmus Hospital, ULB (Free University of Brussels), Brussels, Belgium.

Thierry Gustot (T)

Department of Gastroenterology, Hepatopancreatology and Digestive Oncology, CUB Erasmus Hospital, ULB (Free University of Brussels), Brussels, Belgium.

Delphine Degré (D)

Department of Gastroenterology, Hepatopancreatology and Digestive Oncology, CUB Erasmus Hospital, ULB (Free University of Brussels), Brussels, Belgium.

Nathalie Boon (N)

Department of Gastroenterology, Hepatopancreatology and Digestive Oncology, CUB Erasmus Hospital, ULB (Free University of Brussels), Brussels, Belgium.

Christophe Moreno (C)

Department of Gastroenterology, Hepatopancreatology and Digestive Oncology, CUB Erasmus Hospital, ULB (Free University of Brussels), Brussels, Belgium.

Daniel Blero (D)

Department of Gastroenterology, Hepatopancreatology and Digestive Oncology, CUB Erasmus Hospital, ULB (Free University of Brussels), Brussels, Belgium.

Marianna Arvanitakis (M)

Department of Gastroenterology, Hepatopancreatology and Digestive Oncology, CUB Erasmus Hospital, ULB (Free University of Brussels), Brussels, Belgium.

Myriam Delhaye (M)

Department of Gastroenterology, Hepatopancreatology and Digestive Oncology, CUB Erasmus Hospital, ULB (Free University of Brussels), Brussels, Belgium.

Alain Vandermeeren (A)

Department of Gastroenterology, Hepatopancreatology and Digestive Oncology, CUB Erasmus Hospital, ULB (Free University of Brussels), Brussels, Belgium.

Hassan Njimi (H)

Biomedical Statistic, ULB (Free University of Brussels), Brussels, Belgium.

Jacques Devière (J)

Department of Gastroenterology, Hepatopancreatology and Digestive Oncology, CUB Erasmus Hospital, ULB (Free University of Brussels), Brussels, Belgium.

Olivier Le Moine (O)

Department of Gastroenterology, Hepatopancreatology and Digestive Oncology, CUB Erasmus Hospital, ULB (Free University of Brussels), Brussels, Belgium.

Valerio Lucidi (V)

Department of Abdominal Surgery, CUB Erasmus Hospital, ULB (Free University of Brussels), Brussels, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH